Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Hatzl, S; Greinix, HT; Kreuzer, P; Schulz, E; Neumeister, P; Scherr, D.
A wearable cardioverter defibrillator for prevention of sudden cardiac death in a hematologic patient-a case report
MEMO-MAG EUR MED ONC. 2019; 12(3): 269-271.
Doi: 10.1007/s12254-019-0514-5
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Hatzl Stefan
- Co-authors Med Uni Graz
-
Greinix Hildegard
-
Neumeister Peter
-
Scherr Daniel
-
Schulz Eduard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The wearable cardioverter defibrillator ( WCD) is a suitable option to overcome life-threatening episodes of malignant arrhythmia. There is much experience in the use of these devices in patients with idiopathic arrhythmia as well as in patients at a high risk for sudden cardiac death. However, there is lack of experience with WCD usage in hematologic patients with a limited expected lifespan. Here, we report a rare case ofmalignant arrhythmia in a patient with cardiac relapse of diffuse large B-cell lymphoma (DLBCL) and the option of WCD use. WCD provides the possibility of bridging to implantation of a cardioverter defibrillator (ICD) in cases with a high risk of hemorrhage as well as being a definite therapy in patients with limited life expectance.
- Find related publications in this database (Keywords)
-
WCD
-
Lymphoma
-
Arrhythmia
-
Cardiac relapse
-
(ICD) implantable cardioverter-defibrillator